News / Utah / 

Utah to receive $500,000 from pharmaceutical settlement

Utah to receive $500,000 from pharmaceutical settlement

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

SALT LAKE CITY -- Utah will receive $500,000 as part of a pharmaceutical company settlement.

Attorney General Mark Shurtleff announced that Utah will get a portion of the $750 million settlement with GlaxoSmithKline over allegations the pharmaceutical company sold adulterated drugs.

The whistleblower's complaint alleged GSK knowingly manufactured, distributed and sold four products --Paxil CR, Avandamet, Kytril and Bactroban -- whose strength, purity and/or quality fell below the standards required by the FDA:

  • Paxil CR: A controlled-release antidepressant that included split tablets, causing recipients to receive either product with no active ingredient and/or product with only the active ingredient layer and no controlled release mechanism.
  • Avandamet: A diabetes medication with tablets containing higher or lower amounts of the active ingredient than specified.
  • Kytril: An anti-nausea drug labeled as sterile but with some vials containing impurities.
  • Bactroban: Antibiotic ointments and creams that, in some packages, were contaminated with microorganisms.

Most recent Utah stories

Related topics



    Catch up on the top news and features from, sent weekly.
    By subscribing, you acknowledge and agree to's Terms of Use and Privacy Policy.

    KSL Weather Forecast